BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gijs M, Aerts A, Impens N, Baatout S, Luxen A. Aptamers as radiopharmaceuticals for nuclear imaging and therapy. Nucl Med Biol 2016;43:253-71. [PMID: 26746572 DOI: 10.1016/j.nucmedbio.2015.09.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 González-méndez I, Sorroza-martínez K, Ruiu A, Rivera E. Carbon nanotubes for anticancer therapy: new trends and innovations. Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery 2023. [DOI: 10.1016/b978-0-323-85199-2.00005-4] [Reference Citation Analysis]
2 Alves da Silva FF, Bernardes ES. Selection of aptamers against the Jagged-1 protein. Braz J Rad Sci 2022;10. [DOI: 10.15392/2319-0612.2022.1933] [Reference Citation Analysis]
3 Sun J, Huangfu Z, Yang J, Wang G, Hu K, Gao M, Zhong Z. Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation. Adv Drug Deliv Rev 2022;190:114538. [PMID: 36162696 DOI: 10.1016/j.addr.2022.114538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang X, Gao Y, Deng B, Hu B, Zhao L, Guo H, Yang C, Ma Z, Sun M, Jiao B, Wang L. Selection, Characterization, and Optimization of DNA Aptamers against Challenging Marine Biotoxin Gymnodimine-A for Biosensing Application. Toxins 2022;14:195. [DOI: 10.3390/toxins14030195] [Reference Citation Analysis]
5 Lepareur N, Bourgeois M. Receptor-Specific Radionuclide Therapy. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_303-1] [Reference Citation Analysis]
6 Ozerskaya AV, Zamay TN, Kolovskaya OS, Tokarev NA, Belugin KV, Chanchikova NG, Badmaev ON, Zamay GS, Shchugoreva IA, Moryachkov RV, Zabluda VN, Khorzhevskii VA, Shepelevich N, Gappoev SV, Karlova EA, Saveleva AS, Volzhentsev AA, Blagodatova AN, Lukyanenko KA, Veprintsev DV, Smolyarova TE, Tomilin FN, Zamay SS, Silnikov VN, Berezovski MV, Kichkailo AS. 11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography. Molecular Therapy - Nucleic Acids 2021;26:1159-1172. [DOI: 10.1016/j.omtn.2021.10.020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Dutta B, Barick KC, Hassan PA. Recent advances in active targeting of nanomaterials for anticancer drug delivery. Adv Colloid Interface Sci 2021;296:102509. [PMID: 34455211 DOI: 10.1016/j.cis.2021.102509] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
8 Jaymand M, Davatgaran Taghipour Y, Rezaei A, Derakhshankhah H, Foad Abazari M, Samadian H, Hamblin MR. Radiolabeled carbon-based nanostructures: New radiopharmaceuticals for cancer therapy? Coordination Chemistry Reviews 2021;440:213974. [DOI: 10.1016/j.ccr.2021.213974] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
9 Vi C, Mandarano G, Shigdar S. Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach. Int J Mol Sci 2021;22:6163. [PMID: 34200484 DOI: 10.3390/ijms22116163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ducongé F. Aptamers for Molecular Imaging. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00034-x] [Reference Citation Analysis]
11 Ordoñez AA, Jain SK. Imaging of Bacterial Infections. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00089-2] [Reference Citation Analysis]
12 Sett A. Aptamers: Magic Bullet for Theranostic Applications. Theranostics - An Old Concept in New Clothing [Working Title] 2020. [DOI: 10.5772/intechopen.95403] [Reference Citation Analysis]
13 Jose J, Thomas AM, Mendonsa D, Al-Sanea MM, Uddin MS, Parambi DGT, Charyulu RN, Mathew B. Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle. Curr Drug Targets 2019;20:1624-35. [PMID: 31362673 DOI: 10.2174/1389450120666190729121747] [Reference Citation Analysis]
14 Nuzzo S, Brancato V, Affinito A, Salvatore M, Cavaliere C, Condorelli G. The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature. Cancers (Basel) 2020;12:E2173. [PMID: 32764266 DOI: 10.3390/cancers12082173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
15 Izabella Abreu de Melo M, Rodrigues Correa C, da Silva Cunha P, Miranda de Góes A, Assis Gomes D, Silva Ribeiro de Andrade A. DNA aptamers selection for carcinoembryonic antigen (CEA). Bioorg Med Chem Lett 2020;30:127278. [PMID: 32527457 DOI: 10.1016/j.bmcl.2020.127278] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Zhang GX, Liu YL, Yang M, Huang WS, Xu JH. An aptamer-based, fluorescent and radionuclide dual-modality probe. Biochimie 2020;171-172:55-62. [PMID: 32081705 DOI: 10.1016/j.biochi.2020.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
17 Dos Santos SR, de Barros ALB, de Andrade ASR. Evaluation of the specific uptake of radiolabeled Staphylococcus aureus aptamers in the infectious foci. Appl Radiat Isot 2020;158:109047. [PMID: 31989931 DOI: 10.1016/j.apradiso.2020.109047] [Reference Citation Analysis]
18 Kang L, Rosenkrans ZT, Cai W. 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery. Methods Mol Biol 2019;1974:223-31. [PMID: 31099007 DOI: 10.1007/978-1-4939-9220-1_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Billah AA, Pujiyanto A, Hambali, Lestari E. Recovery of Gold from Radioactive Gold Waste Using The Redox Replacement Method with Zn-Foil Reductor. IOP Conf Ser : Mater Sci Eng 2019;546:022002. [DOI: 10.1088/1757-899x/546/2/022002] [Reference Citation Analysis]
20 Zhang Y, Lai BS, Juhas M. Recent Advances in Aptamer Discovery and Applications. Molecules. 2019;24:pii: E941. [PMID: 30866536 DOI: 10.3390/molecules24050941] [Cited by in Crossref: 261] [Cited by in F6Publishing: 267] [Article Influence: 65.3] [Reference Citation Analysis]
21 Cardinale J, Giammei C, Jouini N, Mindt TL. Bioconjugation Methods for Radiopharmaceutical Chemistry. Radiopharmaceutical Chemistry 2019. [DOI: 10.1007/978-3-319-98947-1_25] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Zhang J, Cao Y. Aptasensors. Nano-Inspired Biosensors for Protein Assay with Clinical Applications. Elsevier; 2019. pp. 139-66. [DOI: 10.1016/b978-0-12-815053-5.00006-4] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Khalid U, Vi C, Henri J, Macdonald J, Eu P, Mandarano G, Shigdar S. Radiolabelled Aptamers for Theranostic Treatment of Cancer. Pharmaceuticals (Basel) 2018;12:E2. [PMID: 30586898 DOI: 10.3390/ph12010002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
24 Salmanoglu E, Kim S, Thakur ML. Currently Available Radiopharmaceuticals for Imaging Infection and the Holy Grail. Semin Nucl Med 2018;48:86-99. [PMID: 29452623 DOI: 10.1053/j.semnuclmed.2017.10.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
25 Hassanzadeh L, Chen S, Veedu RN. Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging. Pharmaceuticals (Basel) 2018;11:E106. [PMID: 30326601 DOI: 10.3390/ph11040106] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
26 Bouvier-Müller A, Ducongé F. Application of aptamers for in vivo molecular imaging and theranostics. Adv Drug Deliv Rev 2018;134:94-106. [PMID: 30125606 DOI: 10.1016/j.addr.2018.08.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]
27 Oliveira C, Parafita R, Canudo A, Castanheira JC, Costa DC. Nuclear Medicine in Oncology. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2018;6:429-446. [DOI: 10.1080/21681163.2016.1254068] [Reference Citation Analysis]
28 Subramanian N, Balachandran A, Subramanian K. Aptamer as Therapeutics for Cancer with Focus on Retinoblastoma. Gene and Cell Therapy: Biology and Applications 2018. [DOI: 10.1007/978-981-13-0481-1_6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Ordonez AA, Jain SK. Pathogen-Specific Bacterial Imaging in Nuclear Medicine. Semin Nucl Med 2018;48:182-94. [PMID: 29452620 DOI: 10.1053/j.semnuclmed.2017.11.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
30 Hays EM, Duan W, Shigdar S. Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications. Int J Mol Sci 2017;18:E2576. [PMID: 29189740 DOI: 10.3390/ijms18122576] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
31 Sicco E, Báez J, Margenat J, García F, Ibarra M, Cabral P, Moreno M, Cerecetto H, Calzada V. Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations. Chem Biol Drug Des 2018;91:747-55. [PMID: 29080264 DOI: 10.1111/cbdd.13135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
32 Komiyama M, Yoshimoto K, Sisido M, Ariga K. Chemistry Can Make Strict and Fuzzy Controls for Bio-Systems: DNA Nanoarchitectonics and Cell-Macromolecular Nanoarchitectonics. BCSJ 2017;90:967-1004. [DOI: 10.1246/bcsj.20170156] [Cited by in Crossref: 228] [Cited by in F6Publishing: 238] [Article Influence: 38.0] [Reference Citation Analysis]
33 Ferreira IM, de Sousa Lacerda CM, Dos Santos SR, de Barros ALB, Fernandes SO, Cardoso VN, de Andrade ASR. Detection of bacterial infection by a technetium-99m-labeled peptidoglycan aptamer. Biomed Pharmacother 2017;93:931-8. [PMID: 28715874 DOI: 10.1016/j.biopha.2017.07.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
34 Santos SRD, de Sousa Lacerda CM, Ferreira IM, de Barros ALB, Fernandes SO, Cardoso VN, de Andrade ASR. Scintigraphic imaging of Staphylococcus aureus infection using 99mTc radiolabeled aptamers. Appl Radiat Isot 2017;128:22-7. [PMID: 28683356 DOI: 10.1016/j.apradiso.2017.06.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
35 Dutta J, Naicker T, Ebenhan T, Kruger HG, Arvidsson PI, Govender T. Synthetic approaches to radiochemical probes for imaging of bacterial infections. European Journal of Medicinal Chemistry 2017;133:287-308. [DOI: 10.1016/j.ejmech.2017.03.060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
36 Tsao SM, Lai JC, Horng HE, Liu TC, Hong CY. Generation of Aptamers from A Primer-Free Randomized ssDNA Library Using Magnetic-Assisted Rapid Aptamer Selection. Sci Rep 2017;7:45478. [PMID: 28367958 DOI: 10.1038/srep45478] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
37 Calzada V, Moreno M, Newton J, González J, Fernández M, Gambini JP, Ibarra M, Chabalgoity A, Deutscher S, Quinn T, Cabral P, Cerecetto H. Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept. Bioorg Med Chem 2017;25:1163-71. [PMID: 28089349 DOI: 10.1016/j.bmc.2016.12.026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
38 de Sousa Lacerda CM, Ferreira IM, Dos Santos SR, de Barros AL, Fernandes SO, Cardoso VN, de Andrade AS. (1→3)-β-D-glucan aptamers labeled with technetium-99m: Biodistribution and imaging in experimental models of bacterial and fungal infection. Nucl Med Biol 2017;46:19-24. [PMID: 27951452 DOI: 10.1016/j.nucmedbio.2016.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
39 Hu J, Ye M, Zhou Z. Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases. J Mol Med (Berl) 2017;95:249-56. [PMID: 27847965 DOI: 10.1007/s00109-016-1485-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
40 Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov 2017;16:181-202. [PMID: 27807347 DOI: 10.1038/nrd.2016.199] [Cited by in Crossref: 887] [Cited by in F6Publishing: 929] [Article Influence: 126.7] [Reference Citation Analysis]
41 Chen K, Liu B, Yu B, Zhong W, Lu Y, Zhang J, Liao J, Liu J, Pu Y, Qiu L, Zhang L, Liu H, Tan W. Advances in the development of aptamer drug conjugates for targeted drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017;9. [PMID: 27800663 DOI: 10.1002/wnan.1438] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
42 Menger M, Yarman A, Erdőssy J, Yildiz HB, Gyurcsányi RE, Scheller FW. MIPs and Aptamers for Recognition of Proteins in Biomimetic Sensing. Biosensors (Basel) 2016;6:E35. [PMID: 27438862 DOI: 10.3390/bios6030035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
43 Lazzeri E. Systematic review of in vivo microorganisms imaging with labeled vitamins, bacteriophages and oligomers. Clin Transl Imaging 2016;4:265-72. [DOI: 10.1007/s40336-016-0182-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]